Orchestra BioMed Holdings Target Price

See Orchestra BioMed Holdings's analyst price targets ($13) vs the current share price.

Get informed when a big investor buys or sells

+ Follow

Share Price

$4.42

Average Target Price

$13.00

194.1% upside

1 analysts in the last 4 months

High: $13 | Low: $13

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

Date	Analyst	Price Target	Current Upside/Downside
2026-05-13	BarclaysMatt Miksic	$13	194.1% upside
2026-01-09	BarclaysMatt Miksic	$12	171.5% upside
2025-03-20	BTIGMarie Thibault	$12	171.5% upside

Orchestra BioMed Holdings (OBIO) FAQ

The latest target price for OBIO is $13. Investors often review this figure alongside Orchestra BioMed Holdings's historical trend and sector peers before judging valuation or financial health.

Orchestra BioMed Holdings trades near $4.42 while the consensus target sits at $13 (194.1% upside). Targets are estimates based on earnings forecasts and valuation models; they change when analysts update ratings or revise models. Compare the average with the high and low targets for a fuller picture.

After noting OBIO's target price ($13), review year-over-year change, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.